Question 1

What is Basaglar?

Accepted Answer

Basaglar is a long-acting insulin used to help regulate blood sugar levels in people with diabetes. It is designed to mimic the natural insulin produced by the body and provides a steady level of insulin over an extended period. Basaglar is commonly associated with the management of both type 1 and type 2 diabetes. Its primary role is to support glucose control and reduce the risk of complications related to high blood sugar.

Question 2

What is Basaglar used for?

Accepted Answer

Basaglar is used to treat type 1 diabetes mellitus and type 2 diabetes mellitus .

Question 3

How does Basaglar work?

Accepted Answer

Regulating Blood Sugar

Basaglar works by replacing the insulin that the body would normally produce. Insulin is a hormone that allows sugar (glucose) in the blood to enter cells throughout the body, where it is used for energy. By facilitating this process, Basaglar helps lower blood sugar levels in people with diabetes.

Liver and Fat Regulation

In addition to helping cells absorb sugar, this medication also signals the liver to stop producing more sugar. It also helps prevent the breakdown of fat and protein, further stabilizing glucose levels in the bloodstream.

Long-Acting Mechanism

Basaglar is classified as a basal, or long-acting, insulin. Unlike rapid-acting insulins that work quickly around mealtimes, Basaglar is designed to be absorbed slowly into the bloodstream. This slow release provides a relatively constant level of insulin for about 24 hours, often referred to as a peakless profile. This helps maintain stable blood sugar levels between meals and overnight.

Question 4

What are the brand names for Basaglar?

Accepted Answer

Basaglar is sold under the brand names Lantus , Toujeo , and Basaglar .

Question 5

What are the active ingredients in Basaglar?

Accepted Answer

The active ingredient in Basaglar is insulin glargine .

Question 6

What are the side effects of Basaglar?

Accepted Answer

Common side effects of Basaglar may include:

Low blood sugar

Injection site reactions

Weight gain

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Basaglar?

Accepted Answer

Basaglar belongs to the long-acting insulin drug class.

Question 8

What is the dosage of Basaglar and how do I take it?

Accepted Answer

Basaglar is administered as an injection under the skin (subcutaneously). It is typically used once a day and should be taken at the same time every day. Common injection sites include the abdomen, thighs, or the back of the upper arms.

When administering this medication, follow these general guidelines:

Rotate injection sites: Use a different spot within the chosen area for each injection. This helps reduce the risk of developing skin problems like lumps, pits, or thickened skin.

Check the solution: The insulin should be clear and colorless. Do not use it if the liquid looks cloudy, colored, or contains visible particles.

Do not mix: Basaglar should not be mixed in the same syringe with any other insulin or diluted with other liquids.

Use a new needle: Always use a new, sterile needle for every injection to prevent infection and ensure the correct dose is delivered.

If you miss a dose of Basaglar, contact your healthcare provider for instructions on when to take your next dose. Do not inject a double dose or extra insulin to make up for a missed one.

Question 9

Is Basaglar safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Maintaining stable blood sugar levels is essential during pregnancy to reduce the risk of complications for both the parent and the developing baby. While studies in pregnant women have not shown that insulin glargine causes birth defects, insulin needs often fluctuate significantly during pregnancy.

Healthcare providers typically monitor blood sugar closely during this time and may adjust the dosage or type of insulin used. If you are pregnant or planning to become pregnant, discuss a management plan with your medical team to ensure blood sugar remains within a target range.

Breastfeeding

It is currently unknown whether insulin glargine passes into human breast milk. Because insulin is a naturally occurring hormone in the body, many forms of insulin are used during breastfeeding, but specific data for this long-acting version is limited.

If you are breastfeeding or planning to breastfeed, consider the following:

Insulin requirements may change while nursing, often requiring a dosage adjustment.

A healthcare provider can help determine if the benefits of using this medication outweigh any potential risks to the infant.

Monitoring the infant for any unusual symptoms is recommended if you are using medication while nursing.

Question 10

What forms and strengths does Basaglar come in?

Accepted Answer

Available Forms

Basaglar is supplied as a sterile solution for subcutaneous injection. It is available in the following formats:

Prefilled Pens: This medication is available in disposable, multi-dose delivery devices, such as the KwikPen and the Tempo Pen.

These devices are used to administer the medication into the layer of fat just under the skin.

Question 11

What is the FDA approval status of Basaglar?

Accepted Answer

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) approved Basaglar to manage blood glucose levels in specific patient populations. Its approved indications include:

Adults and pediatric patients with type 1 diabetes mellitus.

Adults with type 2 diabetes mellitus.

Basaglar is a long-acting insulin designed to provide a steady level of insulin in the body for approximately 24 hours.

Regulatory Classification

Basaglar was approved through an abbreviated regulatory pathway as a follow-on biologic product. This means it was demonstrated to be highly similar to an existing approved insulin glargine product. While it serves the same clinical purpose as other insulin glargine medications, it was not originally classified as an interchangeable biosimilar at the time of its initial approval.

Safety Monitoring and Communications

The FDA monitors the safety of Basaglar through the Adverse Event Reporting System (FAERS). In early 2018, the FDA identified a potential safety signal for the class of insulin glargine products regarding accidental lung exposure, also known as aspiration. The agency monitors these signals to determine if updates to prescribing information or other regulatory actions are required to ensure patient safety.

Question 12

What should I know about Basaglar and cost?

Accepted Answer

Insurance and Pharmacy Factors

The amount a patient pays for Basaglar is largely determined by their insurance provider. Most private insurance plans and Medicare Part D cover Basaglar, but the specific copay or coinsurance amount depends on the plan's drug list, also known as a formulary. Pharmacy prices can also vary between locations, so comparing costs at different pharmacies may be beneficial.

Financial Assistance

The manufacturer of Basaglar may offer savings cards or patient assistance programs to help reduce costs for eligible patients. These programs are often available to those with commercial insurance or those who meet specific income requirements. Patients may also explore state-sponsored programs or non-profit organizations that assist with the cost of diabetes medications.

Cost-Effectiveness

As a follow-on biologic medication, Basaglar is often a more affordable option compared to some other brand-name long-acting insulins. However, because it is not a generic, it may still carry a significant cost for those without adequate insurance coverage. It is important to consult with an insurance provider to determine which insulin products are most cost-effective under a specific plan.

Basaglar

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?